Skip to content

The clinical feasibility of a system for optimizing depression treatment

The clinical feasibility of a system for optimizing depression treatment through integration of medical information: a prospective cohort study - The feasibility of a system for optimizing depression treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052445
Enrollment
30
Registered
2023-10-10
Start date
2023-12-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

None listed

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Research Physician: All of the following must be met (1) Physicians at medical institutions that specialize in psychiatry (ii) A person who understands the purpose and content of the study and has obtained written consent from the individual to participate in the study of his/her own free will. Patients to be studied: Patients who meet all of the following criteria (1) Patients who recognize the diagnostic criteria for depression in DSM-5. (ii) 18 years of age or older at the time consent is obtained (iii) Patients who understand the purpose and content of the study and have given their written consent to participate in the study of their own free will.

Exclusion criteria

Exclusion criteria: Research Physician: Of the cases meeting the above eligibility criteria, those who meet any of the following conditions will be excluded from participation in this study. (i) Those who cannot use a personal computer, smartphone, etc. (ii) Other persons deemed by the principal investigator to be ineligible for the study (e.g., employed by the principal investigator, etc.) Research Patients: Of the patients who meet the above eligibility criteria, those who meet any of the following conditions will be excluded from participation in this study. (i) Patients with a history of severe organic brain lesions or cognitive dysfunction. (ii) Patients with a clinical diagnosis of a serious or unstable life-threatening physical condition at the time of screening. (iii) Other subjects who are judged by the principal investigator to be ineligible for this study.

Design outcomes

Primary

MeasureTime frame
Physicians' difficulty and 3-month retention rate in using the tool

Secondary

MeasureTime frame
For physicians: compliance with the recommended treatment during the 3-month period, expected number of subjects who will use the tool, and contribution to treatment selection. For patients: degree of difficulty in reporting symptoms and of satisfaction with treatment

Countries

Japan

Contacts

Public ContactToshiaki Kikuchi

Keio University School of Medicine Department of Neuropsychiatry

t-kick.z3@keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026